Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

National Taiwan University Hospital, Taipei, Taiwan Region.

Survival: monthsCountry:Taiwan Region
Toxiciy Grade:4City/State/Province:Taipei
Treatments:Biologic therapyHospital:National Taiwan University Hospital
Drugs:Journal:Link
Date:Jan 2009

Description:

Patients:
This phase III study involved 150 advanced hepatocellular carcinoma patients who had no prior chemotherapy. The median age was 51 years and 84.7% were male.

Treatment:
Patients were treated with the biologic therapy agent sorafenib, which blocks cancer cell growth by targeting tyrosine kinase proteins on the cell surface.

Toxicities:
The most severe reported treatment-related toxicities were grade 3-4 hand-foot skin reaction, diarrhea, and fatigue.

Results:
Median overall survival was 6.5 months

Support:
This study was supported by Bayer Pharmaceuticals.

Correspondence: Dr. Ann-Lii Cheng; email: [email protected]



Back